Engineer Jovan Smederevac (1854-1920)
نویسندگان
چکیده
منابع مشابه
Jovan Babić
In the age of globalization and increased interdependence in the world that we face today, there is a question we have to raise: Do we need and could we attain a world government, capable of insuring peace and facilitating worldwide wellbeing in a just and efficient way. We may think that the issue of world governance is something new, but it is not. Every era has its version of ―globalization‖...
متن کاملYves Delage (1854-1920) as a forerunner of modern nuclear transfer experiments.
It is generally considered that animal cloning by nuclear transfer originated in proposals made by Hans Spemann (1936), following his experiments on delayed nucleation in the newt egg, which were preceded by similar attempts using the sea-urchin egg (Loeb, 1894). Briggs and King (1952) were the first to succeed in transplanting blastula and gastrula nuclei into the enucleated frog egg and in ob...
متن کاملDmd065748 1847..1854
The mechanism by which drugs inhibit organic anion transporter 1 (OAT1) was examined. OAT1 was stably expressed in Chinese hamster ovary (CHO) cells, and para-aminohippurate (PAH) and 6-carboxyfluorescein were the substrates. Most compounds (10 of 14) inhibited competitively, increasing the Michaelis constant (Km) without affecting the maximal transport rate (Jmax). Others were mixed-type (lowe...
متن کاملDdf189 1845..1854
Autosomal dominant polycystic kidney disease (ADPKD) occurs by germline mutation in PKD1 or PKD2. Evidence of homozygous inactivation of either gene in human cyst lining cells as well as in mouse knockout models strongly supports a two-hit mechanism for cyst formation. Discovery of trans-heterozygous mutations in PKD1 and PKD2 in a minority of human renal cysts has led to the proposal that such...
متن کاملOp-cbio150070 1854..1856
Motivation: Adoptive T cell therapies based on introduction of new T cell receptors (TCRs) into patient recipient T cells is a promising new treatment for various kinds of cancers. A major challenge, however, is the choice of target antigens. If an engineered TCR can cross-react with self-antigens in healthy tissue, the side-effects can be devastating. We present the first web server for assess...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nasledje
سال: 2018
ISSN: 1450-605X,2560-3264
DOI: 10.5937/nasledje1819055p